Search Within

CTCR Scholars

  1. "JAMA Oncology"
Formats
  1. Journal Article (7)
  2. Editorial (1)
  3. Research Letter (1)
  4. Review (1)
Groups
  1. Department of Medicine (10)
  2. Hematology-Oncology Fellows (8)
  3. Hematologic Malignancies, Division of (6)
  4. Solid Tumor Oncology Division (6)
  5. Biostatistics Service (5)
  6. Epidemiology and Biostatistics (5)

More Groups

People
  1. Anna Varghese (3)
  2. Eileen O'Reilly (3)
  3. Kenneth Yu (3)
  4. Michael Scordo (3)
  5. Urvi Shah (3)
  6. Wungki Park (3)

More People

Years
  1. 2025 (2)
  2. 2024 (1)
  3. 2022 (1)
  4. 2021 (4)
  5. 2020 (2)
Publications
  1. JAMA Oncology (10)
Publishers
  1. American Medical Association (10)

Results (10)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Nonoperative management of technically resectable pancreatic cancer with ablative radiation therapy
    Journal Article

    Reyngold, M.; Schoenfeld, J. D.; O'Reilly, E. M.; Varghese, A. M.; White, C.; Zinovoy, M.; Romesser, P. B.; Wu, A. J.; Hajj, C.; Cuaron, J. J.; more...
    JAMA Oncology (2025)

    Fulltext@MSK | Save
  • Barriers to chimeric antigen receptor T-cell therapy
    Research Letter

    Valtis, Y. K.; Chin, K. K.; Nemirovsky, D.; Devlin, S. M.; Yisraeli Salman, M.; Boussi, L.; Cadzin, B.; McLoughlin, C.; Cathcart, E.; Davis, P.; more...
    JAMA Oncology (2025)

    Fulltext@MSK | Save
  • Lynch syndrome and somatic mismatch repair variants in pancreas cancer
    Journal Article

    O'Connor, C. A.; Harrold, E.; Lin, D.; Walch, H.; Gazzo, A.; Ranganathan, M.; Kane, S.; Keane, F.; Schoenfeld, J.; Moss, D.; more...
    JAMA Oncology (2024)

    Fulltext@MSK | Save
  • Plant-based and ketogenic diets as diverging paths to address cancer: A review
    Review

    Shah, U. A.; Iyengar, N. M.
    JAMA Oncology (2022)

    Fulltext@MSK | Save
  • Association of antineoplastic therapy with decreased SARS-CoV-2 infection rates in patients with cancer
    Journal Article

    Foote, M. B.; White, J. R.; Jee, J.; ArgileĢs, G.; Wan, J. C. M.; Rousseau, B.; Pessin, M. S.; Diaz, L. A. Jr
    JAMA Oncology (2021)

    Fulltext@MSK | Save
  • Outcomes associated with thiotepa-based conditioning in patients with primary central nervous system lymphoma after autologous hematopoietic cell transplant
    Journal Article

    Scordo, M.; Wang, T. P.; Ahn, K. W.; Chen, Y.; Ahmed, S.; Awan, F. T.; Beitinjaneh, A.; Chen, A.; Chow, V. A.; Dholaria, B.; more...
    JAMA Oncology (2021)

    Fulltext@MSK | Save
  • Safety and effectiveness of weekly carfilzomib, lenalidomide, dexamethasone, and daratumumab combination therapy for patients with newly diagnosed multiple myeloma the MANHATTAN nonrandomized clinical trial
    Journal Article

    Landgren, O.; Hultcrantz, M.; Diamond, B.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; Tan, C.; Shah, U. A.; Lu, S. X.; Salcedo, M.; more...
    JAMA Oncology (2021)

    Fulltext@MSK | Save
  • Association of ablative radiation therapy with survival among patients with inoperable pancreatic cancer
    Journal Article

    Reyngold, M.; O'Reilly, E. M.; Varghese, A. M.; Fiasconaro, M.; Zinovoy, M.; Romesser, P. B.; Wu, A.; Hajj, C.; Cuaron, J. J.; Tuli, R.; more...
    JAMA Oncology (2021)

    Fulltext@MSK | Save
  • Cancer and coronavirus disease 2019 (COVID-19) - Facing the "C words"
    Editorial

    Shah, U. A.
    JAMA Oncology (2020)

    Fulltext@MSK | Save
  • Objective response rate among patients with locally advanced or metastatic sarcoma treated with talimogene laherparepvec in combination with pembrolizumab: A phase 2 clinical trial
    Journal Article

    Kelly, C. M.; Antonescu, C. R.; Bowler, T.; Munhoz, R.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Dholakia, R.; more...
    JAMA Oncology (2020)

    Fulltext@MSK | Save